COLL Collegium Pharmaceutical, Inc. Stock Quote

COLL [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	48.22	EPS (ttm)	0.50	Insider Own	1.80%	Shs Outstand	34.54M	Perf Week	10.93%
Market Cap	865.68M	Forward P/E	15.83	EPS next Y	1.52	Insider Trans	-6.56%	Shs Float	32.19M	Perf Month	22.94%
Income	17.60M	PEG	87.67	EPS next Q	0.31	Inst Own	-	Short Float	12.19%	Perf Quarter	14.63%
Sales	307.90M	P/S	2.81	EPS this Y	42.80%	Inst Trans	0.73%	Short Ratio	13.97	Perf Half Y	39.16%
Book/sh	5.00	P/B	4.81	EPS next Y	75.12%	ROA	3.20%	Target Price	27.86	Perf Year	0.59%
Cash/sh	4.60	P/C	5.23	EPS next 5Y	0.55%	ROE	12.60%	52W Range	13.00 - 25.59	Perf YTD	20.12%
Dividend	-	P/FCF	10.56	EPS past 5Y	5.70%	ROI	-24.00%	52W High	-5.98%	Beta	1.08
Dividend %	-	Quick Ratio	1.00	Sales past 5Y	-	Gross Margin	52.20%	52W Low	85.08%	ATR	1.10
Employees	255	Current Ratio	1.10	Sales Q/Q	8.60%	Oper. Margin	12.60%	RSI (14)	72.53	Volatility	4.82% 5.20%
Optionable	Yes	Debt/Eq	1.55	EPS Q/Q	276.40%	Profit Margin	5.70%	Rel Volume	2.07	Prev Close	22.29
Shortable	Yes	LT Debt/Eq	1.27	Earnings	Nov 05 AMC	Payout	0.00%	Avg Volume	280.72K	Price	24.06
Recom	2.10	SMA20	19.65%	SMA50	23.12%	SMA200	25.67%	Volume	582,252	Change	7.94%

Jan-11-21

Reiterated

H.C. Wainwright

Buy

$29 → $33

Jul-14-20

Initiated

BWS Financial

Sell

May-27-20

Initiated

Guggenheim

Neutral

Feb-19-20

Resumed

Jefferies

Buy

$43

Oct-30-19

Reiterated

Needham

Buy

$33 → $25

May-03-19

Resumed

H.C. Wainwright

Buy

$23

Apr-12-19

Resumed

Janney

Buy

$29

Mar-20-19

Initiated

SunTrust

Hold

$22

Jan-16-19

Reiterated

Needham

Buy

$35 → $33

Mar-08-18

Reiterated

H.C. Wainwright

Buy

$21 → $33

Feb-07-18

Reiterated

Needham

Buy

$28 → $35

Dec-05-17

Reiterated

Needham

Buy

$25 → $28

Sep-11-17

Initiated

H.C. Wainwright

Buy

$21

May-11-17

Reiterated

Needham

Buy

$28 → $25

Sep-13-16

Initiated

Gabelli & Co

Buy

$25

Jun-01-15

Initiated

Piper Jaffray

Overweight

$26

Jun-01-15

Initiated

Needham

Buy

$28

Jun-01-15

Initiated

Jefferies

Buy

$20

Jan-06-21 04:01PM	Collegium Provides 2021 Financial Guidance GlobeNewswire +6.99%
Dec-16-20 05:48PM	Is COLL A Good Stock To Buy Now? Insider Monkey
Nov-07-20 08:36AM	Results: Collegium Pharmaceutical, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts Simply Wall St.
Nov-06-20 10:31PM	Collegium Pharmaceutical Inc (COLL) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 05:45PM	Collegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue Estimates Zacks
04:01PM	Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020 GlobeNewswire
02:45PM	Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
06:45AM	Can You Imagine How Collegium Pharmaceutical's (NASDAQ:COLL) Shareholders Feel About The 51% Share Price Increase? Simply Wall St.
Oct-29-20 12:35PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-26-20 08:00AM	Collegium Announces Publication of Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER in Pain Medicine GlobeNewswire
Oct-25-20 07:05AM	Investing $5,000 in These 2 Biotechs Could Make You Rich Motley Fool
Oct-22-20 04:01PM	Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Oct-12-20 01:25PM	Collegium Pharmaceutical Inc (COLL): Hedge Funds Taking Some Chips Off The Table Insider Monkey
Oct-04-20 06:51AM	3 Top Healthcare Stocks You Can Buy Now for Less Than $40 Motley Fool
Sep-30-20 08:00AM	Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation GlobeNewswire
Sep-25-20 08:00AM	Collegium Appoints Rita Balice-Gordon to its Board of Directors GlobeNewswire
Sep-14-20 08:00AM	Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference GlobeNewswire
Sep-09-20 04:05PM	Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference GlobeNewswire
Aug-07-20 11:39AM	Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Could Be 32% Below Their Intrinsic Value Estimate Simply Wall St.
Aug-05-20 07:15PM	Collegium Pharmaceutical (COLL) Q2 Earnings Miss Estimates Zacks
04:01PM	Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020 GlobeNewswire
Aug-04-20 12:04PM	Collegium Pharmaceutical's Earnings: A Preview Benzinga
Aug-03-20 12:59PM	Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ? Insider Monkey +5.51%
Jul-29-20 12:33PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy? Zacks
Jul-21-20 05:00PM	Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
05:00PM	Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Jul-07-20 11:40AM	AMRX vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
Jun-19-20 11:40AM	AMRX vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
09:57AM	Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL) Insider Monkey
Jun-17-20 05:09PM	Collegium Pharmaceutical Named one of Boston Business Journals 2020 Best Places to Work GlobeNewswire
Jun-03-20 11:40AM	AMRX or COLL: Which Is the Better Value Stock Right Now? Zacks
May-27-20 08:44AM	Edited Transcript of COLL earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-18-20 11:40AM	AMRX or COLL: Which Is the Better Value Stock Right Now? Zacks +6.72%
May-13-20 11:06AM	2 Value Stocks That Will Make You Richer in May Motley Fool -7.32%
May-08-20 12:31PM	Collegium Pharmaceutical Inc (COLL) Q1 2020 Earnings Call Transcript Motley Fool +5.61%
06:36AM	The Collegium Pharmaceutical (NASDAQ:COLL) Share Price Is Up 116% And Shareholders Are Boasting About It Simply Wall St.
May-07-20 04:01PM	Collegium Reports First Quarter 2020 Profitability GlobeNewswire
Apr-30-20 12:34PM	Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-23-20 04:01PM	Collegium to Host Conference Call to Discuss First Quarter 2020 Financial Results and Provide Corporate Update GlobeNewswire
Apr-07-20 04:01PM	Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Apr-06-20 09:30AM	Top Ranked Growth Stocks to Buy for April 6th Zacks +8.87%
Apr-01-20 08:50AM	Top Ranked Growth Stocks to Buy for April 1st Zacks -5.14%
Mar-26-20 11:40AM	COLL or NBIX: Which Is the Better Value Stock Right Now? Zacks
Mar-24-20 05:03AM	Edited Transcript of COLL earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents +17.12%
Mar-20-20 07:44AM	Top Ranked Growth Stocks to Buy for March 20th Zacks
Mar-10-20 11:40AM	COLL or NBIX: Which Is the Better Value Stock Right Now? Zacks
08:42AM	Why Collegium (COLL) Could Be an Impressive Growth Stock Zacks
Feb-27-20 04:01PM	Collegium Reports Full-Year 2019 Revenue of $296.7 Million GlobeNewswire
Feb-26-20 01:05PM	Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update GlobeNewswire
Feb-20-20 12:31PM	Earnings Preview: Collegium Pharmaceutical (COLL) Q4 Earnings Expected to Decline Zacks
Feb-13-20 04:01PM	Collegium Announces Closing of the Nucynta Franchise Acquisition GlobeNewswire
Feb-10-20 07:15PM	Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering GlobeNewswire -15.05%
07:20AM	Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering GlobeNewswire
Feb-08-20 07:04AM	What Kind Of Share Price Volatility Should You Expect For Collegium Pharmaceutical, Inc. (NASDAQ:COLL)? Simply Wall St.
Feb-07-20 07:32AM	The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns Benzinga +25.37%
Feb-06-20 04:01PM	Collegium to Acquire U.S. Rights to Nucynta Franchise GlobeNewswire
Jan-31-20 05:00PM	Biohaven Appoints Michael Heffernan To Board Of Directors PR Newswire
Jan-21-20 08:41AM	Prospects Appear Bright for Small Drug Industry in 2020 Zacks -7.90%
Jan-14-20 11:50AM	Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? Zacks
Jan-09-20 08:39AM	The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga
Jan-08-20 08:12AM	The Daily Biotech Pulse: Verastem In-Licenses Chughai's Tumor Drug, Midatech Surges On Positive Study Results Benzinga +11.04%
Jan-07-20 04:05PM	Collegium Provides 2020 Financial Guidance GlobeNewswire
Dec-13-19 11:32AM	These Hedge Funds Cashed Out Of Collegium Pharmaceutical Inc (COLL) Too Early Insider Monkey
Dec-10-19 05:43PM	Edited Transcript of COLL earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-06-19 02:39PM	Hedge Funds Love Unisys Corporation (UIS) Way More Than These 4 Stocks Insider Monkey
Nov-26-19 08:01AM	Collegium to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-08-19 08:14AM	The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut Benzinga +10.89%
08:00AM	Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Nov-06-19 06:25PM	Collegium Pharmaceutical (COLL) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:01PM	Collegium Reports Third Quarter 2019 Financial Results GlobeNewswire
02:16PM	Were Hedge Funds Right About Souring On Collegium Pharmaceutical (COLL)? Insider Monkey
Oct-30-19 10:34AM	Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-23-19 08:00AM	Collegium to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Oct-19-19 10:02AM	Collegium Pharmaceutical (NASDAQ:COLL) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Sep-26-19 04:08PM	Edited Transcript of COLL earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-25-19 08:00AM	Collegium to Participate in Upcoming Investor Conference GlobeNewswire
Sep-23-19 06:00AM	The Opioid Crisis Has Upended Pain Management. Whats Next for the Industry. Barrons.com
Sep-03-19 04:01PM	Collegium to Participate in Upcoming Investor Conferences GlobeNewswire -6.04%
Aug-29-19 04:01PM	Collegium Announces Scientific Presentations at PAINWeek 2019 National Conference GlobeNewswire
Aug-08-19 11:24PM	Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript Motley Fool
12:23AM	Collegium Pharmaceutical, Inc. (COLL) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 06:35PM	Collegium Pharmaceutical (COLL) Q2 Earnings Surpass Estimates Zacks
Jul-31-19 10:36AM	Earnings Preview: Collegium Pharmaceutical (COLL) Q2 Earnings Expected to Decline Zacks
Jul-24-19 04:01PM	Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Jul-23-19 12:19PM	Imagine Owning Collegium Pharmaceutical (NASDAQ:COLL) And Wondering If The 48% Share Price Slide Is Justified Simply Wall St.
Jun-28-19 05:03PM	Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-19-19 10:41AM	Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL) Insider Monkey +6.52%
May-29-19 08:00AM	Collegium to Present at Upcoming Investor Conferences GlobeNewswire
May-09-19 10:03PM	Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call Transcript Motley Fool +5.05%
01:53PM	Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc (COLL) ? Insider Monkey
11:24AM	Assertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call Transcript Motley Fool
May-08-19 05:45PM	Collegium Pharmaceutical (COLL) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:37PM	Collegium Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:01PM	Collegium Reports First Quarter 2019 Financial Results GlobeNewswire
May-06-19 11:54AM	Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up? Zacks +5.15%
May-05-19 09:19AM	2 Big Biotech Stock Upgrades: Can They Reach These Targets? Motley Fool
May-01-19 10:33AM	Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Apr-30-19 04:01PM	Collegium to Participate in Upcoming Investor Conferences GlobeNewswire -7.20%
Apr-24-19 04:01PM	Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Apr-02-19 08:00AM	Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer GlobeNewswire

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. It provides DETERx platform technology that is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods of abuse and misuse, including chewing, crushing, and injecting. The company also offers Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for opioid medication. In addition, it offers Nucynta ER, an extended release formulation of tapentadol for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment, such as neuropathic pain related to diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate release formulation of tapentadol that is indicated for the management of moderate to severe acute pain in adults. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fleming Alison B	Chief Technology Officer	Jan 07	Option Exercise	5.73	16,042	91,921	127,461	Jan 11 05:06 PM
Fleming Alison B	Chief Technology Officer	Jan 07	Sale	22.00	16,042	352,924	111,419	Jan 11 05:06 PM
Fleming Alison B	Chief Technology Officer	Dec 03	Sale	19.24	5,967	114,805	111,419	Dec 07 04:03 PM
Fleming Alison B	Chief Technology Officer	Nov 18	Option Exercise	5.73	16,000	91,680	117,386	Nov 20 04:28 PM
Kuhlmann Shirley R.	EVP and General Counsel	Oct 15	Sale	20.82	7,060	146,989	57,531	Oct 16 04:07 PM
Heffernan Michael Thomas	Director	Aug 11	Sale	19.13	13,071	250,048	54,122	Aug 12 04:05 PM
Dreyer Scott	EVP & Chief Commercial Officer	Jul 13	Sale	17.01	1,429	24,307	46,418	Jul 14 04:06 PM
Ciaffoni Joseph	President and CEO	Jun 02	Sale	20.48	5,861	120,058	192,798	Jun 02 06:58 PM
Ciaffoni Joseph	President and CEO	Jun 01	Option Exercise	8.22	64,820	532,820	269,335	Jun 02 06:58 PM
Ciaffoni Joseph	President and CEO	Jun 01	Sale	21.53	70,676	1,521,709	198,659	Jun 02 06:58 PM
Dreyer Scott	EVP & Chief Commercial Officer	May 18	Option Exercise	15.90	8,000	127,200	56,441	May 20 04:18 PM
Dreyer Scott	EVP & Chief Commercial Officer	May 18	Sale	24.00	8,000	192,000	48,441	May 20 04:18 PM
Fleming Alison B	Chief Technology Officer	May 13	Sale	21.67	7,989	173,147	102,901	May 15 04:16 PM
Heffernan Michael Thomas	Director	May 13	Sale	21.63	19,254	416,421	81,796	May 15 04:17 PM
Dreyer Scott	EVP & Chief Commercial Officer	May 13	Sale	22.61	4,434	100,253	48,441	May 15 04:15 PM
Heffernan Michael Thomas	Director	Jan 21	Option Exercise	5.73	275,463	1,578,403	402,086	Jan 22 04:29 PM
Heffernan Michael Thomas	Director	Jan 21	Sale	21.93	295,287	6,476,863	106,799	Jan 22 04:29 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience